Evidence map›Paper›PMID 30521144›Full record

ArticleThoracic cancer2019

Chinese Expert Consensus Workshop Report: Guideline for permanent iodine-125 seed implantation of primary and metastatic lung tumors.

Fujun Zhang, Junjie Wang, Jinhe Guo, Yuliang Li, Xuequan Huang, Zhiyu Guan, Guangyan Lei, Juan Wang, Xin Ye, Xiaogang Zhao and 3 more

Open access · goldAbstract readConsensus Statement
In one paragraph

Article in Thoracic cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Journal of clinical and translational hepatology · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Frontiers in oncology · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Implantation ofBMC pulmonary medicine · 2019
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 1 country.

Fujun ZhangImaging and Interventional Center, Sun Yat-sen University Cancer Center, Guangzhou, China.
Junjie WangDepartment of Radiation Oncology, Cancer Centre, Peking University Third Hospital, Beijing, China.
Jinhe GuoDepartment of Radiology, Southeast University, Zhongda Hospital, Nanjing, China.
Yuliang LiDepartment of Interventional Medicine, The Second Hospital of Shandong University, Jinan, China.ORCID 0000-0002-0634-7035
Xuequan HuangDepartment of Interventional Medicine, The First Hospital Affiliated to AMU (Southeast Hospital), Chongqing, China.
Zhiyu GuanDepartment of Thoracic Surgery, The Second Hospital of Tianjin Medical University, Tianjin, China.
Guangyan LeiDepartment of Thoracic Surgery, Shaanxi Provincial Cancer Hospital, Xi'an, China.
Juan WangDepartment of Oncology, Hebei General Hospital, Shijiazhuang, China.
Xin YeDepartment of Oncology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Xiaogang ZhaoDepartment of Thoracic Surgery, The Second Hospital of Shandong University, Jinan, China.
Jing WangDepartment of Respiration, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Ruoyu WangDepartment of Oncology, The Affiliated Zhongshan Hospital of Dalian University, Dalian, China.
Bin LiuDepartment of Interventional Medicine, The Second Hospital of Shandong University, Jinan, China.
Shandong University · CNPeking University · CNAffiliated Zhongshan Hospital of Dalian University · CNSecond Hospital of Shandong University · CNSecond Hospital of Tianjin Medical University · CNShanxi Medical University · CNSun Yat-sen University · CNThe Affiliated Yongchuan Hospital of Chongqing Medical University · CNZhongda Hospital Southeast University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surgery remains the first choice of cure for early stage lung cancer. However, many patients are diagnosed at advanced stage, and thus miss the opportunity to undergo surgery. As such patients derive limited benefits from chemotherapy or radiotherapy, alternatives focusing on local control have emerged, including iodine-125 seed implantation. The Interstitial Brachytherapy Society, Committee of Minimally Invasive Therapy in Oncology, Chinese Anti-Cancer Association organized a group of multidisciplinary experts to develop guidelines for this treatment modality. These guidelines aim to standardize iodine-125 seed implantation procedures, inclusion criteria, and outcome assessment to prevent and manage procedure-related complications.

Indexed as

BrachytherapyNeoplasm SeedingHumansIodine RadioisotopesLung NeoplasmsPractice Guidelines as TopicPractice Patterns, Physicians'PrognosisRadiotherapy DosageRadiotherapy Planning, Computer-AssistedIodine-125Iodine RadioisotopesGuidelineimplantationiodine-125lung malignancy

Identifiers

PMID30521144
PMCPMC6360234
OpenAlexW2903750966

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.